Cogent Biosciences
COGT
COGT
136 hedge funds and large institutions have $814M invested in Cogent Biosciences in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 45 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
4% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 45
5% less capital invested
Capital invested by funds: $859M → $814M (-$44.4M)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
136
Holding in Top 10
5
Calls
$149K
Puts
$59K
Top Buyers
| 1 | +$24.1M | |
| 2 | +$9.69M | |
| 3 | +$9.14M | |
| 4 |
CC
Commodore Capital
New York
|
+$4.88M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$4.32M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$11.4M | |
| 3 | -$9.98M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$6.03M |